2017
DOI: 10.1055/s-0037-1602666
|View full text |Cite
|
Sign up to set email alerts
|

Thromboprophylaxis in Cancer Patients Undergoing Surgery

Abstract: Venous thromboembolism (VTE) is a common, complex, and costly complication in cancer patients undergoing surgery. VTE risk varies with types of cancer surgery as well as patient-, cancer-, and treatment-associated factors. Current VTE preventive measures with pharmacological, mechanical, and combination of both are shown to be effective. Clinical questions remain and more research is needed, focusing on the role of thromboprophylaxis for minimally invasive surgery and major cancer surgery other than abdominal/… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
2
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
2
1
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 77 publications
(63 reference statements)
0
2
0
Order By: Relevance
“…3 Exploring these clinical dilemmas, Htun and Lee summarize the evidence on the efficacy and safety of primary thromboprophylaxis in cancer patients undergoing surgery, also taking into account the influence of cancer type on thromboembolic risk; they also present the current consensus recommendations in this setting. 4 Pediatric cardiac surgery affords special challenges in regard to management of hemostasis. First of all, hemostasis in children differs from that in adults, 5 making interpretation of laboratory tests challenging.…”
mentioning
confidence: 99%
“…3 Exploring these clinical dilemmas, Htun and Lee summarize the evidence on the efficacy and safety of primary thromboprophylaxis in cancer patients undergoing surgery, also taking into account the influence of cancer type on thromboembolic risk; they also present the current consensus recommendations in this setting. 4 Pediatric cardiac surgery affords special challenges in regard to management of hemostasis. First of all, hemostasis in children differs from that in adults, 5 making interpretation of laboratory tests challenging.…”
mentioning
confidence: 99%
“…3 Exploring these clinical dilemmas, Htun and Lee summarize the evidence on the efficacy and safety of primary thromboprophylaxis in cancer patients undergoing surgery, also taking into account the influence of cancer type on thromboembolic risk; they also present the current consensus recommendations in this setting. 4 Pediatric cardiac surgery affords special challenges in regard to management of hemostasis. First of all, hemostasis in children differs from that in adults, 5 making interpretation of laboratory tests challenging.…”
mentioning
confidence: 99%